Morquio Disease

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
CENTOGENEGermany - Rostock
1 program
Establishment of Human Cellular Disease Models for Morquio DiseaseN/A1 trial
Active Trials
NCT03872713Completed40Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CENTOGENEEstablishment of Human Cellular Disease Models for Morquio Disease

Clinical Trials (1)

Total enrollment: 40 patients across 1 trials

NCT03872713CENTOGENEEstablishment of Human Cellular Disease Models for Morquio Disease

Establishment of Human Cellular Disease Models for Morquio Disease

Start: Oct 2018Est. completion: Dec 201940 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space